We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Trent Carrier, Ph.D. is the Chief Operating Officer of CytoSen Therapeutics. Dr. Carrier has extensive expertise in multiple biotherapeutic platforms and more than 20 years of scientific, business, and executive management experience in the biotechnology industry. He joined CytoSen from Takeda Vaccines where he served as Vice President of Vaccine Technology and Engineering where he worked on vaccines for norovirus and dengue virus. Prior to Takeda, Dr. Carrier was the Chief Business Officer at Biologics Consulting Group, a regulatory and product development consulting firm. Prior to that, Dr. Carrier served as the Head of Cellular Medicine at Life Technologies, where he had responsibility for the Cell Therapy Systems (CTS TM) product portfolio. Dr. Carrier received his Ph.D. in chemical engineering from the University of California, Berkeley and his MBA from the Darden School of Business at the University of Virginia.
This speaker's sessions: